Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer.
Capecitabine (CAP) is a 5-FU pro-drug approved for the treatment of several cancers and it is used in combination with gemcitabine (GEM) in the treatment of patients with pancreatic adenocarcinoma (PDAC). However, limited pre-clinical data of the effects of CAP in PDAC are available to support the u...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Public Library of Science (PLoS)
2013-01-01
|
| Seri Bilgileri: | PLoS ONE |
| Online Erişim: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0067330&type=printable |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|